Rodman David Malcom: insider trades.
Rodman David Malcom reported 11 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($692K), across 1 company.
- Transactions
- 11
- Purchases (P)
- 0
- Sales (S)
- 5
- Companies
- 1
- Name as filed
- Rodman David Malcom
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | Officer · Chief Medical Officer | 11 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-10 | Mineralys Therapeutics, Inc. | M | 2,170 | $16 | 53,554 | Form 4 |
| 2026-08-10 | Mineralys Therapeutics, Inc. | S | 2,170 | $27.09 | 51,384 | Form 4 |
| 2026-07-17 | Mineralys Therapeutics, Inc. | M | 416 | $15.44 | 51,800 | Form 4 |
| 2026-07-17 | Mineralys Therapeutics, Inc. | S | 416 | $26.53 | 51,384 | Form 4 |
| 2026-07-15 | Mineralys Therapeutics, Inc. | S | 6,349 | $26.61 | 51,384 | Form 4 |
| 2026-07-13 | Mineralys Therapeutics, Inc. | M | 4,167 | $14.25 | 65,442 | Form 4 |
| 2026-07-13 | Mineralys Therapeutics, Inc. | S | 14,058 | $27.58 | 57,733 | Form 4 |
| 2026-07-13 | Mineralys Therapeutics, Inc. | M | 3,542 | $10.2 | 61,275 | Form 4 |
| 2026-07-13 | Mineralys Therapeutics, Inc. | M | 6,349 | $1.08 | 71,791 | Form 4 |
| 2026-07-09 | Mineralys Therapeutics, Inc. | M | 2,171 | $16 | 59,904 | Form 4 |
| 2026-07-09 | Mineralys Therapeutics, Inc. | S | 2,171 | $30.3 | 57,733 | Form 4 |
Questions
What stock did Rodman David Malcom buy or sell?
Rodman David Malcom reported 11 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($692K), across 1 company.
Is Rodman David Malcom the same person as other filers with this name?
This page covers SEC CIK 1672659 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/rodman-david-malcom-1672659.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.